Snapshot from Aug 25, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / United States — United States Securities and Exchange Commission / Revolution Medicines

United States — United States Securities and Exchange Commission & Revolution Medicines

1 shared events · Importance 3 · Last updated Aug 10, 2026

Importance
3
Shared Events
1
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
Shared Events (1)
37
Regulatory
Erasca Securities Fraud Class Action
United States — United States Securities and Exchange Commission: The SEC is referenced in connection with whistleblower program and potential regulatory scrutiny of Erasca's disclosures.
Revolution Medicines: Revolution Medicines is the competitor whose patent and trade secret claims against Erasca triggered the stock drop. The allegations could strengthen its competitive position in the RAS-targeting space.
Jun 11, 2026 · 193 articles
ERGEN INTELLIGENCE
Explore this relationship live

Track how United States — United States Securities and Exchange Commission and Revolution Medicines interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.